leisure time -WSS

leisure time

author：explore 2025-09-27 10:02:13 - browse：8467

Andrea Coravos, managing director at ICON, speaks at the STAT Breakthrough Summit West in San Francisco Thursday as Ida Sim, chief research informatics officer at UCSF, looks on. Sarah Gonzalez for STAT

Just because the Food and Drug Administration has given the Apple Watch and other wearable devices the OK to market the health benefits of their tracking and algorithms doesn’t mean that the data they generate are useful for either patients or their doctors, experts said Thursday at the STAT Breakthrough Summit West in San Francisco.

“Yesterday, I saw a patient with type 2 diabetes who has a continuous glucose monitor, and so she’s been tracking her blood sugar every five minutes,” said Ida Sim, a primary care physician and chief research informatics officer at the University of California, San Francisco. “[I] sat with her for almost an hour yesterday. I couldn’t get to her CGM data — she had it on her phone, but the report goes into a website that I didn’t have the login to, and it hadn’t been downloaded into my electronic medical record. So all this tracking data, I didn’t have it.”

Not only do clinicians not have the ability to access data that their patients want to use to guide their care, but primary care doctors often don’t know how to interpret that firehose of data, said Sim. She asked some of her endocrinology research colleagues how they use that data and they explained the calculations needed to create biomarker metrics from them. That made the data largely useless to her as a doctor, and it was frustrating.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： FogPharma raises $145 million in rare Series E round

focus

WSS

House looks to weaken Medicare negotiation

Change Healthcare cyberattack outage could last weeks

App could help diagnose ear infections more accurately — and at home

U.K. researchers warn about biases in medical devices, algorithms

Orchard's therapy for neuron disease in children wins FDA approval

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

23andMe had bad news about my health. I wish a person had delivered it

Flu vaccine offering decent levels of protection this winter, new data show

Peter Hotez and the public health issue of online harassment

Asbestos, a deadly carcinogen, banned by EPA

Jerome Adams on the need for new antivirals for Covid

House looks to weaken Medicare negotiation

Alkermes shareholders re

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

hotspot

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

AstraZeneca to buy developer of next

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

RSV vaccines may be linked to small increased risk of developing GBS

Biotech companies concerned about China biosecurity crackdown

Methadone treatment changes are coming. Do they go far enough?

focus

explore

focus

hotspot